SHL Stock Overview
Offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Sonic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$26.61 |
| 52 Week High | AU$36.94 |
| 52 Week Low | AU$23.60 |
| Beta | 0.50 |
| 1 Month Change | -0.038% |
| 3 Month Change | -5.84% |
| 1 Year Change | -25.13% |
| 3 Year Change | -29.55% |
| 5 Year Change | -2.78% |
| Change since IPO | 51.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHL | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 6.4% | 4.3% | 0.1% |
| 1Y | -25.1% | -20.2% | 6.2% |
Return vs Industry: SHL underperformed the Australian Healthcare industry which returned -20.2% over the past year.
Return vs Market: SHL underperformed the Australian Market which returned 6.2% over the past year.
Price Volatility
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in AU Market | 15.9% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months.
Volatility Over Time: SHL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 41,000 | Colin Goldschmidt | www.sonichealthcare.com |
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services.
Sonic Healthcare Limited Fundamentals Summary
| SHL fundamental statistics | |
|---|---|
| Market cap | AU$12.78b |
| Earnings (TTM) | AU$504.94m |
| Revenue (TTM) | AU$8.39b |
25.3x
P/E Ratio1.5x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL income statement (TTM) | |
|---|---|
| Revenue | AU$8.39b |
| Cost of Revenue | AU$5.62b |
| Gross Profit | AU$2.77b |
| Other Expenses | AU$2.26b |
| Earnings | AU$504.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.05 |
| Gross Margin | 32.99% |
| Net Profit Margin | 6.02% |
| Debt/Equity Ratio | 32.2% |
How did SHL perform over the long term?
See historical performance and comparison